DK1838318T3 - Anvendelse af oxycodon til behandling af visceral smerte - Google Patents

Anvendelse af oxycodon til behandling af visceral smerte

Info

Publication number
DK1838318T3
DK1838318T3 DK06700652T DK06700652T DK1838318T3 DK 1838318 T3 DK1838318 T3 DK 1838318T3 DK 06700652 T DK06700652 T DK 06700652T DK 06700652 T DK06700652 T DK 06700652T DK 1838318 T3 DK1838318 T3 DK 1838318T3
Authority
DK
Denmark
Prior art keywords
oxycodone
treatment
visceral pain
visceral
pain
Prior art date
Application number
DK06700652T
Other languages
Danish (da)
English (en)
Inventor
Asbjorn Mohr Drewes
Lars Arendt Nielsen
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35871217&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1838318(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Application granted granted Critical
Publication of DK1838318T3 publication Critical patent/DK1838318T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
DK06700652T 2005-01-18 2006-01-17 Anvendelse af oxycodon til behandling af visceral smerte DK1838318T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64549005P 2005-01-18 2005-01-18
PCT/EP2006/050252 WO2006077212A1 (en) 2005-01-18 2006-01-17 Use of oxycodone for treating visceral pain

Publications (1)

Publication Number Publication Date
DK1838318T3 true DK1838318T3 (da) 2010-01-04

Family

ID=35871217

Family Applications (2)

Application Number Title Priority Date Filing Date
DK06700652T DK1838318T3 (da) 2005-01-18 2006-01-17 Anvendelse af oxycodon til behandling af visceral smerte
DK200700207U DK200700207U3 (da) 2005-01-18 2007-07-24 Anvendelse af oxycodon til behandling af visceral smerte

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK200700207U DK200700207U3 (da) 2005-01-18 2007-07-24 Anvendelse af oxycodon til behandling af visceral smerte

Country Status (31)

Country Link
US (2) US20080200493A1 (enExample)
EP (1) EP1838318B1 (enExample)
JP (1) JP5049139B2 (enExample)
KR (10) KR20190135557A (enExample)
CN (1) CN101106996B (enExample)
AP (1) AP2249A (enExample)
AR (1) AR052880A1 (enExample)
AT (2) ATE446092T1 (enExample)
AU (1) AU2006207498B2 (enExample)
BR (1) BRPI0606247A2 (enExample)
CA (1) CA2595043C (enExample)
CY (1) CY1109660T1 (enExample)
DE (2) DE602006009899D1 (enExample)
DK (2) DK1838318T3 (enExample)
EA (1) EA013544B1 (enExample)
ES (1) ES2333901T3 (enExample)
HR (1) HRP20090679T1 (enExample)
IL (1) IL184530A (enExample)
ME (1) ME01066B (enExample)
MX (1) MX2007007207A (enExample)
MY (1) MY144471A (enExample)
NO (1) NO338968B1 (enExample)
NZ (1) NZ555852A (enExample)
PL (1) PL1838318T3 (enExample)
PT (1) PT1838318E (enExample)
RS (1) RS51069B (enExample)
SI (1) SI1838318T1 (enExample)
TW (1) TWI432196B (enExample)
UA (1) UA85471C2 (enExample)
WO (1) WO2006077212A1 (enExample)
ZA (1) ZA200705231B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3045182T1 (en) 2005-11-14 2018-08-31 Teva Pharmaceuticals International Gmbh An antibody to a peptide-associated peptide antagonist to calcitonin for treating a headache in aggregates
US8821928B2 (en) 2007-06-04 2014-09-02 Egalet Ltd. Controlled release pharmaceutical compositions for prolonged effect
KR101304150B1 (ko) 2008-03-04 2013-09-05 라브리스 바이올로직스 인코포레이티드 만성 통증의 치료 방법
NZ594207A (en) 2009-02-06 2013-03-28 Egalet Ltd Immediate release composition resistant to abuse by intake of alcohol
AU2010265213B2 (en) 2009-06-24 2012-08-23 Egalet Ltd. Controlled release formulations
BR112012004464B8 (pt) * 2009-08-28 2021-05-25 Labrys Biologics Inc uso de um anticorpo antagonista anti-cgrp para preparar uma composição farmacêutica para tratar e/ou prevenir dor visceral e/ou um ou mais sintomas de dor visceral, em que a dor visceral está associada á cistite intersticial (ic), e dita composição farmacêutica
CN108014334B (zh) 2011-05-20 2021-11-30 H.伦德贝克公司 抗cgrp抗体和抗体片段用于在有需要的受试者中预防或抑制畏光或厌光的用途
PT3495392T (pt) 2011-05-20 2021-09-22 H Lundbeck As Composições anti-cgrp e a sua utilização
EA033109B1 (ru) 2011-05-20 2019-08-30 Олдербайо Холдингз Ллк Способы ингибирования, профилактики или лечения диареи и/или поддержания соответствующих уровней электролитов и жидкости в толстой кишке субъекта, подвергающегося связанному с диареей состоянию, с помощью антитела против cgrp или фрагмента антитела против cgrp
US20170114122A1 (en) 2015-10-23 2017-04-27 Alderbio Holdings Llc Regulation of glucose metabolism using anti-cgrp antibodies
US10556945B2 (en) 2014-03-21 2020-02-11 Teva Pharmaceuticals International Gmbh Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
MX378344B (es) 2014-03-21 2025-03-10 Teva Pharmaceuticals Int Gmbh Anticuerpos antagonistas dirigidos contra el peptido relacionado con el gen de calcitonina y metodos que usan los mismos.
SMT202600087T1 (it) 2016-09-23 2026-03-09 Teva Pharmaceuticals Int Gmbh Trattamento dell’emicrania refrattaria
BR112021006027A2 (pt) 2018-11-19 2021-06-29 Jazz Pharmaceuticals Ireland Limited formulações de fármaco resistente a álcool
CR20210373A (es) 2019-01-08 2021-08-19 H Lundbeck As Tratamiento agudo y tratamiento rápido de la cefalea usando anticuerpos anti-cgrp
GEAP202515803A (en) 2019-05-02 2025-06-10 H Lundbeck As Treatment of headache using anti-cgrp antibodies
KR20210124867A (ko) 2020-04-06 2021-10-15 하. 룬드벡 아크티에셀스카브 항-cgrp 항체를 사용하는 편두통 관련 성가심 증상 (mbs) 의 치료

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656295A (en) * 1991-11-27 1997-08-12 Euro-Celtique, S.A. Controlled release oxycodone compositions
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5958459A (en) * 1991-12-24 1999-09-28 Purdue Pharma L.P. Opioid formulations having extended controlled released
IL110014A (en) * 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
PL187926B1 (pl) * 1996-03-25 2004-11-30 Lilly Co Eli Kompozycja farmaceutyczna do leczenia bólu
UA81224C2 (uk) * 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
US6992193B2 (en) * 2003-06-10 2006-01-31 Adolor Corporation Sulfonylamino phenylacetamide derivatives and methods of their use

Also Published As

Publication number Publication date
NO338968B1 (no) 2016-11-07
KR20170021905A (ko) 2017-02-28
MX2007007207A (es) 2007-08-15
US20150190393A1 (en) 2015-07-09
IL184530A (en) 2015-01-29
KR20140091782A (ko) 2014-07-22
DE202006019887U1 (de) 2007-07-26
PL1838318T3 (pl) 2010-03-31
CN101106996B (zh) 2013-10-23
MY144471A (en) 2011-09-30
NO20074174L (no) 2007-10-17
AU2006207498B2 (en) 2009-11-19
SI1838318T1 (sl) 2010-02-26
DK200700207U1 (da) 2007-08-24
ES2333901T3 (es) 2010-03-02
TW200637554A (en) 2006-11-01
KR20230170811A (ko) 2023-12-19
IL184530A0 (en) 2007-10-31
HK1107933A1 (en) 2008-04-25
NZ555852A (en) 2010-01-29
ZA200705231B (en) 2008-06-25
ATE446092T1 (de) 2009-11-15
AU2006207498A1 (en) 2006-07-27
KR20070100368A (ko) 2007-10-10
AR052880A1 (es) 2007-04-11
AP2249A (en) 2011-07-18
HRP20090679T1 (hr) 2010-01-31
CA2595043A1 (en) 2006-07-27
RS51069B (sr) 2010-10-31
AP2007004057A0 (en) 2007-08-31
BRPI0606247A2 (pt) 2009-06-09
KR20210131450A (ko) 2021-11-02
AT9895U1 (de) 2008-05-15
KR20220165797A (ko) 2022-12-15
CN101106996A (zh) 2008-01-16
JP5049139B2 (ja) 2012-10-17
KR20190135557A (ko) 2019-12-06
US20080200493A1 (en) 2008-08-21
US9271974B2 (en) 2016-03-01
EA200701541A1 (ru) 2008-02-28
EA013544B1 (ru) 2010-06-30
PT1838318E (pt) 2009-12-15
CA2595043C (en) 2013-11-19
TWI432196B (zh) 2014-04-01
EP1838318B1 (en) 2009-10-21
WO2006077212A1 (en) 2006-07-27
ME01066B (me) 2012-10-20
JP2008526927A (ja) 2008-07-24
CY1109660T1 (el) 2014-08-13
UA85471C2 (ru) 2009-01-26
DK200700207U3 (da) 2007-09-28
KR20200128451A (ko) 2020-11-12
KR20120089710A (ko) 2012-08-13
KR20080106991A (ko) 2008-12-09
EP1838318A1 (en) 2007-10-03
DE602006009899D1 (de) 2009-12-03

Similar Documents

Publication Publication Date Title
DE602005027052D1 (de) Endoskopbehandlungssystem
DK2409728T3 (da) System til ultralydsbehandling af væv
SMAP200900085A (it) 3-imidazolil-indoli per il trattamento di malattieproliferative
ZA200705231B (en) Use of oxycodone for treating visceral pain
DK2117525T3 (da) Anvendelse af 1-phenyl-3-dimethylamino-propanforbindelser til behandling af neuropatismerte
DK3424932T3 (da) Bronophthalider til terapeutisk anvendelse
HUE054495T2 (hu) Rák kezelésére szolgáló készítmény
EP1854415A4 (en) SURGICAL TREATMENT DEVICE
CY2200156T2 (el) Επεξεργασια λυματων
DK1928438T3 (da) Anvendelse af ibudilast til behandling af stofafhængighed
NO20070251A (no) Brønnbehandling
NO20070297A (no) Brønnbehandling
DK3403657T3 (da) Anvendelse af oligouronater til behandling af slimhyperviskositet
DK1685834T3 (da) Anvendelse af pinolensyre til behandling af obesitet
DK1863899T3 (da) Hudbehandlingspræparater
PT1763520E (pt) Utilização de benzopiranonas trissubstituídas
EP1968591A4 (en) TREATMENT OF SYNUCLEINOPATHIES
DE602005021084D1 (de) ENDOSKOPisches BEHANDLUNGSSYSTEM
IL192933A0 (en) Benzoisoindole derivatives for the treatment of pain
PL1890705T3 (pl) Zastosowanie 24-nor-UDCA do leczenia cholestatycznych chorób wątroby
DK3332789T3 (da) Cladribinkur til behandling af multipel sklerose
FI20051207A0 (fi) Selän hoitolaite
EP1878443A4 (en) THERAPEUTIC AGENT AGAINST NEUROPATHIC PAIN
GB0602857D0 (en) The treatment of sialorrhoea
GB0412262D0 (en) Use of compounds for the treatment of pain